John Hancock Investors Trust

Form 4Def-14A13G

Insider Trading (Form 4)

NYSE
Christine Hurtsellers, a Director at John Hancock Investors Trust, has filed a Form 4 reporting transactions related to common shares.
NYSE
John Hancock Investors Trust Director Kenneth J. Phelan acquired 730 common shares at an approximate price of $13.75 per share.
NYSE
Director Thomas Rowe Wright purchased 875 common shares of John Hancock Investors Trust (JHI) at $12.5698 per share on April 8, 2025.
NYSE
Trustee William K. Bacic reports the acquisition of 719 common shares of John Hancock Investors Trust on January 14, 2025.
NYSE
Trustee Noni L. Ellison reports purchasing additional common shares of John Hancock Investors Trust.

Proxy Statements (Def-14A)

NYSE
John Hancock Investors Trust is soliciting shareholder votes for the election of thirteen trustees at its annual meeting scheduled for February 17, 2026.
NYSE
John Hancock Investors Trust is holding its annual shareholder meeting on February 18, 2025, to vote on the election of twelve trustees.

Schedule 13G - Passive Investments

NYSE
1607 Capital Partners, LLC has reported beneficial ownership of 350,331 shares, representing 4.01% of the common stock in John Hancock Investors Trust.
NYSE
First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation jointly reported a 4.79% beneficial ownership stake in John Hancock Investors Trust as of December 31, 2025.
NYSE
Sit Investment Associates, Inc. and its subsidiary Sit Fixed Income Advisors II, LLC have disclosed a beneficial ownership of 5.1% in John Hancock Investors Trust, holding 441,920 shares of common stock.
NYSE
1607 Capital Partners, LLC has filed a Schedule 13G, revealing a beneficial ownership of 6.14% of the Common Stock of John Hancock Investors Trust.